FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/08/015505 [Registered on: 28/08/2018] Trial Registered Prospectively
Last Modified On: 11/10/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To see the heart rate and blood pressure changes during start of anesthesia by giving two diffrent dose of dexmedetomidine at starting of the anesthesia 
Scientific Title of Study   Comparison of different dose of dexmedetomidine in attenuation of hemodynamic response during Laryngoscopy 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Arun Muthukumar GL 
Designation  DNB TRAINEE 
Affiliation  Sri ramakrishna hospital 
Address  Department of anesthesia 2nd floor(old building), sri ramakrishna hospital, No. 395, Sarojini Naidu Rd, Balasundaram Layout, B.K.R Nagar, New Siddhapudur, Coimbatore, Tamil Nadu 641044

Coimbatore
TAMIL NADU
641044
India 
Phone  8973004700  
Fax    
Email  mailtodoctorarun@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Muthukumar 
Designation  Consultant anesthetist 
Affiliation  Sri ramakrishna hospital 
Address  Department of anesthesia, 2nd floor (old block) , Sri ramakrishna hospital, No: 395, Sarojini Naidu Rd, Balasundaram Layout, B.K.R Nagar, New Siddhapudur, Coimbatore, Tamil Nadu 641044

Coimbatore
TAMIL NADU
641044
India 
Phone    
Fax    
Email  muthu74@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Arun Muthukumar GL 
Designation  DNB TRAINEE 
Affiliation  Sri ramakrishna hospital 
Address  Department of anesthesia, 2nd floor (old building), Sri ramakrishna hospital, No: 395, Sarojini Naidu Rd, Balasundaram Layout, B.K.R Nagar, New Siddhapudur, Coimbatore, Tamil Nadu 641044

Coimbatore
TAMIL NADU
641044
India 
Phone  8973004700  
Fax    
Email  mailtodoctorarun@gmail.com  
 
Source of Monetary or Material Support  
not applicable 
 
Primary Sponsor  
Name  Sri ramakrishna hospital 
Address  No: 395, Sarojini Naidu Rd, Balasundaram Layout, B.K.R Nagar, New Siddhapudur, Coimbatore, Tamil Nadu 641044 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Arun Muthukumar GL  Sri ramakrishna hospital.  Department of anesthesia, 2nd floor(old building), Sri ramakrishna hospital, No: 395, Sarojini Naidu Rd, Balasundaram Layout, B.K.R Nagar, New Siddhapudur, Coimbatore, Tamil Nadu 641044
Coimbatore
TAMIL NADU 
8973004700

mailtodoctorarun@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri ramakrishna hospital ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z768||Persons encountering health services in other specified circumstances, (2) ICD-10 Condition: Z409||Encounter for prophylactic surgery, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexmedetomidine 0.5 microgram / kg  Dexmedetomidine 0.5 microgram / kg during intubation with routine induction agents TIME : For 10 minutes at the start of anesthesia 
Intervention  Dexmedetomidine 0.75 microgram /kg  Dexmedetomidine 0.75 microgram /kg at intubation with regular induction agents 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA GRADE I AND II patients
Patients schedulded for elective surgery under general anesthesia
Patients who provide consent for the study 
 
ExclusionCriteria 
Details  > ASA III PATIENTS
Patients with suspected difficulty in intubation resulting in more than one attempt or > 30 sec taken
Patients who refused to consent for the study
Patients allergic to study drug
Patients who are pregnant, patient on any antidepressants, antipsychotics, patients having history of drug abuse. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Attenuation of Hemodynamic response during Laryngoscopy by safe dose of dexmedetomidine when used along with fentanyl  1-03-2019 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size
Modification(s)  
Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   N/A 
Date of First Enrollment (India)
Modification(s)  
01/09/2018 
Date of Study Completion (India) 01/03/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

Introduction:

The most common method used for maintaining a secured airway during general anaesthesia is endotracheal intubation using direct laryngoscopy1.  Laryngoscopy, endotracheal intubation are linked with hemodynamic changes and increased sympathetic system activity2. Such increased stimulus leads to increase in blood pressure, tachycardia, arrhythmia, increased oxygen consumption, decreased diastolic filling and reduced coronary blood flow3.

The above events start within 5 seconds of laryngoscopy and peaks in 1 to 2 minutes and returns to normal in 5 minutes in normal people4. In moribund patients and those with cardio vascular disease, hypertension and myocardial insufficiency it can cause catastrophic effects5.

Many drugs, either alone or in combination, are used for attenuating such hemodynamic response by increasing the depth of anesthesia, local anesthetic aerosols, high doses of opioids like fentanyl and recently alpha-2 agonist dexmedetomidine. In all these drugs a basic need is continuously felt among anesthetists to have such desired effects at a dose of drug that effectively surpasses all obnoxious stimuli with maximum safety margin6.

So this study is planned with above view to compare the effects of different dose of intravenous dexmedetomidine when used along with usual standard dose of intravenous fentanyl to elicit the safe dose of dexmedetomidine with maximum benefits.

Review of Literature:

A literary search on various articles revealed that Hall JE et al, Gerlach et al have studied the analgesic, sedation, anxiolytic, sympatholytic and blunting of exaggerated hemodynamic responses by administration of dexmedetomidine, mediated by the activation of  alpha-2 receptors located in the post-synaptic terminals in the central nervous system, which causes decreased neuronal activity, augmentation of the vagal activity7,8.

Abou-Arab MH et al has highlighted that the use of intravenous opioids alone in varying doses for suppression of stress response has significant incidence of side-effects, especially with higher doses of opioids9.

Belleville JP et al has compared intravenous dexmedetomidine       1 mcg/kg and 2 mcg/kg used alone but with a significant incidence of bradycardia and hypotension in such higher doses10.

Based on the above literature we planned to study on comparison of 0.5 and 0.75 mcg/Kg of intravenous dexmedetomidine when used along with intravenous fentanyl to elicit the dose which has both the desired effect and also lesser side effects.

Aims and Objectives:

The study is aimed at:

·       Attenuation of hemodynamic response during laryngoscopy by use of intravenous dexmedetomidine along with intravenous fentanyl.

With the objectives:

·       To compare intravenous dexmedetomidine at 0.5 and        0.75 mcg /kg when used along with intravenous fentanyl at standard 2 mcg/kg.

·       To elicit the safe dose of intravenous dexmedetomidine among the two doses which has least side effect.

 

Material and Methods:

Study site                      :        Department of Anaesthesia,

Sri Ramakrishna Hospital.

Study population        :        Patients of age group 18 to 60 years posted for elective surgeries under general anesthesia during study period.

 

o   Inclusion Criteria:     

Ø ASA grade I and II patients.

Ø Patients scheduled for elective surgery under general anesthesia.

Ø Patients who provide consent for the study.

o   Exclusion Criteria:

Ø >ASA grade III patients.

Ø Patients with suspected difficulty in intuabtion resulting in more than one attempt or > 30 sec taken.

Ø Patients who refused to consent for the study.

Ø Patients allergic to study drug.

Ø Patient who are pregnant, patient on any antidepressant, antipsychotics, patients having history of drug abuse.

 

Study Design               : A prospective randomized double blinded study.

 

Sample size with justification: The sample size was estimated from previous study done by Telikota et al 11. Taking the mean HR at 5 min, mean difference of 7.91, standard deviation of 9.1,  at 95% confidence limit, 90% power  and with expected 10 percent erroneous sample the sample size was calculated as 30 (27.7+2.7) in each group  using the below formula.

Sample size        = 2SD2(Z alpha +Z Beta)2/d2

SD    = standard deviation    = 9.1

 d      = mean differnece        = 7.91

From z table; Z alpha / 2 = Z 0.05 /2 = Z 0.025 = 1.96 ; Z beta = Z 0.90 = 1.2815

Sample size         = 2 X (9.1 X 9.1)2 (1.96 + 1.28)2 / ( 7.91 X 7.91 )2

= 27.7

Adding 10 percent erroneous to the above = 27.7 + 2.7

Sample size         = ~30 in each group

Groups       :       

Ø Group D1 [Dexmedetomidine 0.5mcg/kg]

Ø Group D2 [Dexmedetomidine 0.75mcg/kg]


Methodology:  After getting prior consent, patient participating in the study will be received at preop room and baseline vital parameters will be monitored. Randomization will be done using sealed envelope method. Then patients will be preloaded with IV fluids RL at 7ml/kg.

Patients will be then shifted to OT and connected to vitals monitor standard intubation procedure will be followed uniformly for all patients. Patients will be given intravenous ondansetron at 0.15mg/KG and intravenous glycopyrrolate at 0.004mg/kg and preoxygenated for 3 minutes

The study drug prepared by an anaesthetist who is not a part of the study will be administered as:

o   Group D1 will be infused with intravenous dexmedetomidine at 0.5 mcg/kg in 100ml NS over 10 mins

o   Group D2 with intravenous dexmedetomidine 0.75 mcg/kg  in 100ml NS over  10 mins respectively.

o   Both the groups will be infused with intravenous 2mcg/kg fentanyl in 5ml NS over 1 min.

Patients will be induced with propofol at 2mg/kg, after ensuring ventilation can be maintained patients will be given Atracurium at 0.4mg/kg and intubated after 3 minutes. Patients will be maintained with air, oxygen, sevoflurane titrated to effect.

Any episode of severe bradycardia <50 beats per minute in patients will be treated with intravenous atropine, severe hypotension of Mean Arterial Pressure < 60 mmHg will be treated with intravenous fluids, intravenous ephedrine and such patients will be excluded from the study

 

 

Parameters noted will be recorded as follows

o   ID number

o   Demographic data:

§  Age, Male/Female, Weight

o   and 6 readings of Heart Rate, Mean Arterial Pressure, SpO2 at

§  T preop room

§  After infusion

§  Post intubation T 0min, T 1min, T 3min, T 5min.

Incision and surgery will proceed after 5 min


References:

1.     Yallapragada S, Vutukuri G, Vemuri N, Shaik M. Dexmedetomidine and sodium bicarbonate as adjuvants to epidural lidocaine: A comparative study. Ain-Shams Journal of Anaesthesiology. 2016;9(2):256.

2.     Black T, Kay B, Healy T. Reducing the haemodynamic responses to laryngoscopy and intubation. 1984;39(9):883–887.

3.    Bansal S, Pawar M. Haemodynamic responses to laryngoscopy and intubation in patients with pregnancy-induced hyperten- sion: effect of intravenous esmolol with or without lidocaine. International Journal of Obstetric Anesthesia. 2002;11(1):4-8.

4.    Rose D, Cohen M. The airway: problems and predictions in 18,500 patients. Canadian Journal of Anaesthesia. 1994;41(5):372-383.

5.    Kovac A. Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. Journal of Clinical Anesthesia. 1996;8(1):63-79.

6.    Bajwa S, Singh A, Singh G, Gupta S, Panda A, Kaur J et al. Attenuation of pressor response and dose sparing of opioids and anaesthetics with pre-operative dexmedetomidine. Indian Journal of Anaesthesia. 2012;56(2):123.

7.    Hall J, Uhrich T, Barney J, Arain S, Ebert T. Sedative, amnestic and analgesic properties of small-dose Dexmedetomidine infusions. Anesthesia Analgesia. 2000;90(3):699–705.

8.    Gerlach A, Dasta J. Dexmedetomidine: An updated review. Annals of Pharmacotherapy. 2007;4(2):245–254.

9.    Abou-Arab M, Heier T, Caldwell JE. Dose of alfentanil needed to obtain optimal intubation conditions during rapid-sequence induction of anaesthesia with thiopentone and rocuronium. BJA: British Journal of Anaesthesia. 2007;98(5):604–610.

10.  Belleville J, Ward D, Bloor B, Maze M. Effects of intravenous dexmedetomidine in humans. Anesthesiology. 1992;77:1125-1133.

11.  Talikoti A, Sebastian B, Krishnamurty D. Attenuation of hemodynamic responses to laryngoscopy and endotracheal intubation with intravenous dexmedetomidine: A comparison between two doses. Indian Journal of Anaesthesia. 2017;61(1):48.


                         Summary

      Endotracheal intubation using direct laryngoscopy establishes a definitive airway during general anaesthesia. It provides maximal protection against the aspiration of gastric contents and allows for positive pressure ventilation with high airway pressures, when compared with facemask and supraglottic airway devices.  Laryngoscopy and endotracheal intubation are linked with hemodynamic changes and increased sympathetic system activity like increase in blood pressure, tachycardia, arrhythmia, increased oxygen consumption, decreased diastolic filling and reduced coronary blood flow. In moribund patients and those with cardio vascular disease, it can cause catastrophic effects. Various techniques, drugs in different doses has been used in past for attenuation of such hemodynamic responses. In this study we compared the attenuation of such hemodynamic responses namely heart rate, mean blood pressure by 0.5 mcg/kg and 0.75 mcg/kg of intravenous dexmedetomidine during laryngoscopy in induction technique where opioid is routinely used and to elicit the safe dose of dexmedetomidine with maximum benefits. Two groups of total 60 patients with 30 in each group were taken and study was carried out after randomization and double blinding. Standard intubation procedure was followed in both groups. The results were analysed and there was no statistically significant difference between both groups in attenuating the hemodynamic parameters namely heart rate, mean blood pressure during laryngoscopy. Hence we recommend 0.5 mcg/kg of dexmedetomidine as a safe dose for attenuating the hemodynamic response during laryngoscopy in induction technique where opioid is used.


 
Close